0001567619-23-007776.txt : 20231127 0001567619-23-007776.hdr.sgml : 20231127 20231127163124 ACCESSION NUMBER: 0001567619-23-007776 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231127 DATE AS OF CHANGE: 20231127 EFFECTIVENESS DATE: 20231127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Centrexion Therapeutics Corp CENTRAL INDEX KEY: 0001592052 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320402377 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498138 FILM NUMBER: 231440644 BUSINESS ADDRESS: STREET 1: 200 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: (617) 837-6911 MAIL ADDRESS: STREET 1: 200 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Centrexion Corp DATE OF NAME CHANGE: 20131114 D 1 primary_doc.xml X0708 D LIVE 0001592052 Centrexion Therapeutics Corp 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 617-837-6911 DELAWARE None Centrexion Corp Corporation true Jeffrey B. Kindler 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director James N. Campbell, M.D. 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director Randall M. Stevens 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Michael J. Ward 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Sol Barer, Ph.D. 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Director Colin Hill 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Director J.C. Lopez, M.D. 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Director Joseph R. Swedish 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Director Shawn Tomasello 200 State Street, 6th Floor Boston MA MASSACHUSETTS 02109 Director Biotechnology Decline to Disclose 06b false 2023-11-14 false true true true false 0 Maxim Group LLC 120708 None None 300 Park Avenue 16th Floor New York NY NEW YORK 10022 All States false FCC Ltd. None None None 121-123 Menachem Begin Rd 30th Floor Tel Aviv L3 ISRAEL 00000 true 2300000 2300000 0 false 2 230000 true 0 The aggregate compensation payable to Maxim Group LLC and FCC Ltd. under the total offering amount is estimated to consist of (i) a cash fee (listed above) and (ii) warrants to purchase up to 141,333 shares of Centrexion's common stock. 0 false Centrexion Therapeutics Corp /s/ Michael Ward Michael Ward Chief Financial Officer, Treasurer, and Secretary 2023-11-27